SCHEMBL6985955

SCHEMBL6985955

CC(CCNC(=O)c1ccc(C(F)(F)F)cc1)CC(=O)NC1(C)C(=O)COC1C

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.37
CD274 Q9NZQ7 1/20 0.36
BACE1 P56817 1/20 0.36
DPP4 P27487 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
LMNA P02545 1/20 0.34
MCHR1 Q99705 1/20 0.34
EPHX2 P34913 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
DHODH Q02127 1/20 0.34
PDE2A O00408 1/20 0.34
GCGR P47871 1/20 0.34
GCG P01275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6989326 0.92 RAB9A (0.38) NPC1RAB9ALMNAMEN1KMT2A
SCHEMBL6986218 0.89 TRPV1 (0.40) MCHR1EPHX2DHODH
SCHEMBL6985875 0.89 LMNA (0.40) NPC1RAB9ALMNAMCHR1MEN1
SCHEMBL6985259 0.87 HDAC1 (0.40) NAMPTNPC1RAB9AKMT2A
SCHEMBL6987802 0.86 KMT2A (0.41) BACE1NPC1RAB9ALMNAEPHX2
SCHEMBL6987790 0.86 TAS1R3 (0.38) NAMPTNPC1RAB9A
SCHEMBL6986287 0.84 CHRM4 (0.39) DPP4NPC1RAB9A
SCHEMBL6990430 0.81 GCGR (0.41) GCGR
SCHEMBL6996553 0.80 DPP4 (0.37) NAMPTCD274DPP4MCHR1EPHX2
SCHEMBL6753439 0.76 CTSK (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362042-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-19 EP disclosed
WO-2002057249-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed